These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29667765)

  • 1. Molecular profile of inflammatory and megakaryocytic factors in pediatric myelodysplastic syndrome with acute myelofibrosis.
    Hussein K; Suttorp M; Stucki-Koch A; Baumann I; Niemeyer CM; Kreipe H
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27048. PubMed ID: 29667765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
    Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
    Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of fibrosis-related gene transcripts and megakaryocytic changes in the bone marrow of myelodysplastic syndromes with fibrosis.
    Hussein K; Stucki-Koch A; Kreipe H
    Ann Hematol; 2018 Nov; 97(11):2099-2106. PubMed ID: 29961094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrosis-driving cells in patients with primary myelofibrosis and myelodysplastic syndromes with myelofibrosis].
    Cai YN; Zhang PH; Fang LH; Liu JQ; Li B; Xu ZF; Qin TJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):1002-1007. PubMed ID: 33445847
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
    Akiyama T; Matsunaga T; Terui T; Miyanishi K; Tanaka I; Sato T; Kuroda H; Takimoto R; Takayama T; Kato J; Yamauchi N; Kogawa K; Sakamaki S; Hirayama Y; Kohda K; Niitsu Y
    Leukemia; 2005 Sep; 19(9):1558-66. PubMed ID: 16034467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of clinical features and prognosis of primary myelodysplastic syndromes with myelofibrosis patients].
    Su T; Zhang PH; Xu ZF; Chen HS; Qin TJ; Zhang Y; Zhang HL; Fan LW; Pan LJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):378-82. PubMed ID: 22781796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients.
    Maschek H; Georgii A; Kaloutsi V; Werner M; Bandecar K; Kressel MG; Choritz H; Freund M; Hufnagl D
    Eur J Haematol; 1992 Apr; 48(4):208-14. PubMed ID: 1592101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The morphology features of bone marrow in the prefibrotic-early primary myelofibrosis].
    Gong XB; Zhang XH; Lu XG; Tang QS; Gao X; Yang J
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):25-30. PubMed ID: 22575188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.
    Muth M; Engelhardt BM; Kröger N; Hussein K; Schlué J; Büsche G; Kreipe HH; Bock O
    Ann Hematol; 2011 Jan; 90(1):33-40. PubMed ID: 20625903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are micromegakaryocytes specific for refractory cytopenia of childhood (RCC)? A study of 38 pediatric patients with thrombocytopenia unrelated to RCC.
    Aqil B; Punia JN; Curry CV; Marcogliese AN; Elghetany MT
    Leuk Res; 2016 Aug; 47():84-7. PubMed ID: 27285854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis.
    Hussein K; Stucki-Koch A; Göhring G; Kreipe H; Suttorp M
    Leukemia; 2017 Jul; 31(7):1540-1546. PubMed ID: 28239144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity.
    Lambertenghi-Deliliers G; Orazi A; Luksch R; Annaloro C; Soligo D
    Br J Haematol; 1991 Jun; 78(2):161-6. PubMed ID: 1712222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases.
    Pagliuca A; Layton DM; Manoharan A; Gordon S; Green PJ; Mufti GJ
    Br J Haematol; 1989 Apr; 71(4):499-504. PubMed ID: 2640542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelofibrosis in primary myelodysplastic syndromes: clinical and biological significance.
    Marisavljević D; Rolović Z; Cemerikić V; Bosković D; Colović M
    Med Oncol; 2004; 21(4):325-31. PubMed ID: 15579916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
    Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
    Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelofibrosis in cats with myelodysplastic syndrome and acute myelogenous leukemia.
    Blue JT
    Vet Pathol; 1988 Mar; 25(2):154-60. PubMed ID: 2834859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].
    Hu T; Shi XD; Feng YL; Liu R; Li JH; Chen J; Wang TY
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):183-7. PubMed ID: 15833188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.
    Åström M; Hahn-Strömberg V; Zetterberg E; Vedin I; Merup M; Palmblad J
    Am J Hematol; 2015 Mar; 90(3):E44-8. PubMed ID: 25421114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.
    Fu B; Ok CY; Goswami M; Xei W; Jaso JM; Muzzafar T; Bueso-Ramos C; Verstovsek S; Garcia-Manero G; Medeiros LJ; Wang SA
    Ann Hematol; 2013 Oct; 92(10):1335-43. PubMed ID: 23660629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis.
    Alvarez-Larrán A; López-Guerra M; Rozman M; Correa JG; Hernández-Boluda JC; Tormo M; Martínez D; Martín I; Colomer D; Esteve J; Cervantes F
    Ann Hematol; 2019 Oct; 98(10):2319-2328. PubMed ID: 31396671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.